Skip to main content
SpringerLink
Log in

Scale-Up of Protein Purification: Downstream Processing Issues

  • Protocol
  • First Online:
Protein Chromatography

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1485))

Abstract

Separation science continues to occupy the central position in the overall strategy for the downstream processing and purification of therapeutic protein products for human use. Increasing product titers from mammalian cell culture and new emerging classes of biopharmaceuticals has presented a challenge to the industry to identify ways of improving the robustness and economics of chromatography processes. In commercial manufacturing, there is always a need to increase the scale of the chromatography operations which are typically developed and optimized in small-scale laboratory experiments. This review discusses the key factors in the chromatography process that need to be considered as the scale of the purification step is increased in order to maintain the purity and integrity of the product purified at smaller scale.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Kálmán-Szekeres Z, Olajos M, Ganzler K (2012) Analytical aspects of biosimilarity issues of protein drugs. J Pharm Biomed Anal 69:185–195

    Article  PubMed  Google Scholar 

  2. Guiochon G, Beaver LA (2011) Separation science is the key to successful biopharmaceuticals. J Chromotogr A 1218:8836–8858

    Article  CAS  Google Scholar 

  3. Walsh G (2014) Biopharmaceutical benchmarks 2014. Nat Biotechnol 32:992–1000

    Article  CAS  PubMed  Google Scholar 

  4. McAtee AG, Templeton N, Young JD (2014) Role of Chinese hamster ovary central carbon metabolism in controlling the quality of secreted biotherapeutic proteins. Pharm Bioprocess 2:63–74

    Article  Google Scholar 

  5. Zhu J (2012) Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv 30:1158–1170

    Article  CAS  PubMed  Google Scholar 

  6. Costa AR, Rodrigues ME, Henriques M, Azeredo J, Oliveira R (2010) Guidelines to cell engineering for monoclonal antibody production. Eur J Pharm Biopharm 74:127–138

    Article  Google Scholar 

  7. D’Souza RN, Azevedo AM, Aires-Barros MR, Krajnc NL, Kramberger P, Carbajal ML, Grasselli M, Meyer R, Fernandez-Lahore M (2013) Emerging technologies for the integration and intensification of downstream bioprocesses. Pharm Bioprocess 1:423–440

    Article  Google Scholar 

  8. Gottschalk U, Brorson K, Abhinav A (2013) Innovation in biomanufacturing: the only way forward. Pharm Bioprocess 1:141–157

    Article  Google Scholar 

  9. Curling J, Gottschalk U (2007) Process chromatography: five decades of innovation. BioPharm Int 20(10):70–93

    CAS  Google Scholar 

  10. Jungbauer A (2013) Continuous downstream processing of biopharmaceuticals. Trends Biotechnol 31:479–492

    Article  CAS  PubMed  Google Scholar 

  11. Klutz S, Magnus J, Lobedann M, Schwan P, Maiser B, Niklas J, Temming M, Schembecker G (2015) Developing the biofacility of the future based on continuous processing and single-use technology. J Biotechnol 213:120–130

    Article  CAS  PubMed  Google Scholar 

  12. Warikoo V, Godawat R, Brower K, Sujit J, Cummings D, Simons E, Johnson T, Walther J, Yu M, Wright B, McLarty J, Karey KP, Hwang C, Weichang Z, Riske F, Konstantinov K (2012) Integrated continuous production of recombinant therapeutic proteins. Biotechnol Bioeng 109:3018–3029

    Article  CAS  PubMed  Google Scholar 

  13. Sofer G (2005) Guidelines to process validation. In: Rathore AS, Sofer G (eds) Process validation in manufacturing of biopharmaceuticals. CRC Press Taylor and Francis Group, Boca Raton, FL

    Chapter  Google Scholar 

  14. Edwards J (1997) Large-scale column chromatography—a GMP manufacturing perspective. In: Goldberg E (ed) Handbook of downstream processing. Blackie Academic & Professional, London, pp 167–184

    Chapter  Google Scholar 

  15. O’Neil P, Sellick I (2004) Innovations that improve process column chromatography. Filtr Sep 41:24–27

    Article  Google Scholar 

  16. Gagnon P (2012) Technology trends in antibody purification. J Chromatogr A 1221:57–70

    Article  CAS  PubMed  Google Scholar 

  17. GE Healthcare Life Sciences (2011) Two-step purification of monoclonal IgG1 from CHO cell culture supernatant. Application Note 28-9078-92 AD

    Google Scholar 

  18. International Conference on Harmonisation (ICH) Topic Q7 (2000) Good manufacturing practice guide for active pharmaceutical ingredients, CPMP/ICH/4106/00

    Google Scholar 

  19. Lopes AG (2015) Single-use in the biopharmaceutical industry: a review of current technology impact, challenges and limitations. Food Bioproducts Process 93:98–114

    Article  Google Scholar 

  20. Shukla A, Gottschalk U (2013) Single-use disposable technologies for biopharmaceutical manufacturing. Trends Biotechnol 31:147–154

    Article  CAS  PubMed  Google Scholar 

  21. Tebbey PW, Varga A, Naill M, Clewell J, Venema J (2015) Consistency of quality attributes for the glycosylated monoclonal antibody Humira® (adalimumab). mAbs 7(5):805–811

    Google Scholar 

  22. Sofer G, Hagel L (1997) Purification design, optimisation and scale-up. In: Sofer G, Hagel L (eds) Handbook of process chromatography: a guide to optimisation, scale-up and validation. Academic, New York, pp 27–113

    Google Scholar 

  23. Rathore A, Velayudhan A (2003) Guidelines for optimisation and scale-up in preparative chromatography. BioPharm Int 16(1):34–42

    CAS  Google Scholar 

  24. Janson JC, Hedman P (1982) Large-scale chromatography of proteins. In: Fiechter A (ed) Advances in biochemical engineering, vol 25. Springer, New York, pp 43–99

    Google Scholar 

  25. Aldington S, Bonnerjea J (2007) Scale-up of monoclonal antibody purification processes. J Chromatogr B 848:64–78

    Article  CAS  Google Scholar 

  26. Graumann K, Ebenbichler A-A (2005) Development and scale-up of preparative HIC for the purification of a recombinant therapeutic protein. Chem Eng Technol 28:1398–1406

    Article  CAS  Google Scholar 

  27. Mazzer AR, Perraud X, Halley J, O’Hara J, Bracewell DG (2015) Protein A chromatography increases monoclonal antibody aggregation rate during subsequent low pH virus inactivation hold. J Chromatogr A 1415:83–90

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Ghose S, Hubbard B, Cramer SM (2006) Evaluation and comparison of alternatives to Protein A chromatography, mimetic and hydrophobic charge induction chromatographic stationary phases. J Chromatogr A 1122:144–152

    Article  CAS  PubMed  Google Scholar 

  29. Gottschalk U (2008) Bioseparation in antibody manufacturing: the good, the bad and the ugly. Biotechnol Prog 24:496–503

    Article  CAS  PubMed  Google Scholar 

  30. Bemberis I, Noyes A, Natarajan A (2003) Column packing for process-scale chromatography: guidelines for reproducibility. BioPharm Int. Guide. July 23–30

    Google Scholar 

  31. Bloomingburg G, Gandhi P (2005) Engineering design considerations for column packing in large-scale biotechnology facilities. BioProcess Int 3(6):44–51

    Google Scholar 

  32. Rathore AS, Kennedy RM, O’Donnell K, Bemberis I, Kaltenbrunner O (2003) Qualification of a chromatographic column, why and how to do it? BioPharm Int 16(3):30–40

    Google Scholar 

  33. Rathore AS, Sofer G (2005) Life span studies for chromatography and filtration media. In: Rathore AS, Sofer G (eds) Process validation in manufacturing of biopharmaceuticals. CRC Press Taylor and Francis Group, Boca Raton, FL, pp 169–203

    Google Scholar 

  34. Sofer G, Yourkin J (2007) Cleaning and cleaning validation in process chromatography. BioProcess Int 5(10):72–82

    Google Scholar 

  35. Sofer G, Chirica LC (2007) Improving productivity in downstream processing. Pharm Technol Europe 19(4):35–41

    CAS  Google Scholar 

  36. Vogel JH, Nguyen H, Giovanni R, Ignowski J, Garger S, Salgotra A, Tom J (2012) A new large-scale manufacturing platform for complex biopharmaceuticals. Biotechnol Bioeng 109:3049–3058

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institute for Bioprocessing Research and Training (NIBRT), Foster’s Avenue, Blackrock, Co., Dublin, Ireland

    John Joseph Milne

Authors
  1. John Joseph Milne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John Joseph Milne .

Editor information

Editors and Affiliations

  1. School of Biotechnology, Dublin City University, Dublin, Ireland

    Dermot Walls

  2. Department of Applied Sciences, Dundalk Institute of Technology, Dublin, Ireland

    Sinéad T. Loughran

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this protocol

Cite this protocol

Milne, J.J. (2017). Scale-Up of Protein Purification: Downstream Processing Issues. In: Walls, D., Loughran, S. (eds) Protein Chromatography. Methods in Molecular Biology, vol 1485. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6412-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6412-3_5

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-6410-9

  • Online ISBN: 978-1-4939-6412-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation